Trial Profile
A phase I clinical trial of VAS-203 for the treatment of traumatic brain injury
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Aug 2015
Price :
$35
*
At a glance
- Drugs Ronopterin (Primary)
- Indications Traumatic brain injuries
- Focus Adverse reactions; First in man
- 27 Aug 2015 New trial record